2016 Hematological Malignancies
HDR2 Study for Relapsed HL PFS by Treatment Arm (Final Analysis)
Probability 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 0
P = 0.505
Standard (at 3y: 72%)
Intensified (at 3y: 67%)
12
24
36
48
60
Time, months
Josting et al, JCO 2010
Made with FlippingBook